- Initiated by Zanofi’s decision to cut in half the price of Zaltrap after MSKCC said it would not use the drug because it was too expensive, the Health Affairs Blog examines how the “buy and bill” pricing system works, and how it operates in the case of Zaltrap.
- Medgadget reports that IBM’s work with WellPoint and MSKCC on the development of Watson has progressed beyond concept. Now, hospitals and other provider institutions who sign up can buy or rent Watson’s advice from the cloud or their own server.
- The Digital Journal announced that physicians at MSKCC will begin the “first-in-man” drug therapy on mesothelioma patients.